Protagenic Therapeutics, Inc.\new (PTIX) › Capital ExpendituresProtagenic Therapeutics, Inc.\new (PTIX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2022: $1.8K2023: $149.8K$149.8K2022Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$149.8K+8197.8%2022$1.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share